Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Novocure Inc. (NVCR) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Novocure Inc. (NVCR) lobbying for?
Summary of Lobbying Data:
Novocure Inc. hired four lobbying firms – Llc, Downs & Young, Tarplin, and Novocure Inc. – to lobby on general issues such as transportation, health issues, veterans, Medicare/Medicaid, and budget/appropriations. They lobbied on several specific issues such as user fee reauthorization policies, Veteran Affairs Issues, TSA Issues, and consolidation/continuing appropriations acts. The company also lobbied many government agencies, including the Office of Science & Technology Policy (OSTP), White House Office, House of Representatives, Department of Health & Human Services (HHS), Senate, Centers For Medicare and Medicaid Services (CMS), Transportation Security Administration (TSA), and Department of Homeland Security (DHS).
Inference about Novocure Inc.’s Lobbying:
One could infer that Novocure Inc. is lobbying on issues related to its business interests. The company is involved in the development and commercialization of innovative therapies for the treatment of cancer and brain tumors. Therefore, it is likely that Novocure Inc. is lobbying on issues related to Medicare/Medicaid, transportation, and veterans to ensure that their medical technologies are covered, accessible, and available to patients across the country. Further, lobbying government agencies such as the HHS, CMS, and OSTP implies that Novocure Inc. is seeking regulatory support and guidance for its medical technologies. Overall, Novocure Inc.’s lobbying efforts aim to support the growth and expansion of its business, while increasing the availability and affordability of its medical technologies to patients in need.
